Cellectar Biosciences (NASDAQ: CLRB) is developing phospholipid drug conjugates (PDCs) designed to provide cancer-targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. The company’s lead therapeutic PDC, CLR 131, utilizes iodine-131, a cytotoxic … Continue reading →

EyeGate Pharma (NASDAQ: EYEG) is a late-stage specialty pharmaceutical company focused on developing and commercializing therapeutics and drug delivery mechanisms for treating diseases of the eye. The company’s technology addresses two of the most prevalent issues in ophthalmic care: the … Continue reading →

TapImmune (OTCQB: TPIV) is an immunotherapy company specializing in the development of innovative technologies for the treatment of cancer and infectious diseases. The company’s peptide or nucleic acid-based immunotherapeutics comprise one or more naturally processed epitopes designed to comprehensively stimulate … Continue reading →

Car Charging Group (OTC: CCGI) is a pioneer in nationwide public electric vehicle (EV) charging services that enable EV drivers to easily recharge at locations throughout the United States. Headquartered in Miami Beach, Florida, Car Charging Group also has offices … Continue reading →

PAVmed (NASDAQ: PAVMU) is a multi-product medical device company developing and commercializing a diversified pipeline of innovative products which address unmet clinical needs. The company’s goal is to enhance and accelerate value creation by employing a business model focused on … Continue reading →

Spring Bank Pharmaceuticals (NASDAQ: SBPH) is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using its proprietary small molecule nucleic acid hybrid, or SMNH, chemistry platform. The company is developing its most … Continue reading →

IZEA, Inc. (NASDAQ: IZEA) has created and operates an online marketplace designed to connect brands with influential content creators. IZEA’s content creators range from leading bloggers and social media personalities to A-List celebrities and professional journalists. These creators are compensated … Continue reading →

Great Basin Scientific (NASDAQ: GBSN) is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The company is dedicated to the development of simple, yet powerful, sample-to-result technology and products that provide fast, multiple-pathogen diagnoses of infectious diseases. Great Basin’s … Continue reading →

Emerald Medical Applications (OTC: MRLA) owns the Dermacompare Medical App, a cloud-based, artificial intelligence technology that enables photos, taken from almost all digital cameras, to detect the suspicion of melanoma. The FDA-registered, HIPPA-compliant app, available from any App store, enables … Continue reading →